AJU IB Investment 13F-HR Quarterly holdings report by institutional manager

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL

OMB Number:		3235-0006
Expires:	Oct 31, 2018
Estimated average burden
hours per response:		23.8

COLUMN 1	COLUMN 2	COLUMN 3	COLUMN 4	COLUMN 5			COLUMN 6	COLUMN 7	COLUMN 8
			VALUE	SHRS OR	SH/	PUT/	INVESTMENT	OTHER	VOTING AUTHORITY
NAME OF ISSUER	TITLE OF CLASS	CUSIP	(x$1000)	PRN AMT	PRN	CALL	DISCRETION	MANAGER	SOLE	SHARED	NONE
KYMERA THERAPEUTICS INC	COM	501575104	29,019	457,059	SH		SOLE		457,059	0	0
RALLYBIO CORP	COM	75120L100	7,200	754,678	SH		SOLE		754,678	0	0
RAPT THERAPEUTICS INC	COM	75382E109	3,655	99,503	SH		SOLE		99,503	0	0
SEER INC	COM CL A	81578P106	18,622	816,375	SH		SOLE		816,375	0	0
SUTRO BIOPHARMA INC	COM	869367102	2,604	175,000	SH		SOLE		175,000	0	0
XILIO THERAPEUTICS INC	COM	98422T100	10,684	667,742	SH		SOLE		667,742	0	0